Susan Giacalone, MSN, BCMAS, MSL-BC
National Director, Field Medical
Susan leads field medical efforts for EVERSANA and MacroGenics in the commercialization of MARGENZA™ (margetuximab). As a leader in the life sciences industry, she brings more than 20 years of medical affairs experience across multiple therapeutic areas, including oncology, hepatology and rare diseases, and she has successfully commercialized products in all market phases. Susan’s career has included numerous senior-level positions, and she earned the MSL Society’s U.S. Manager of the Year award in 2020. At EVERSANA, she supports the treatment of patients with metastatic HER2-positive breast cancer by providing personalized outreach to prescribers to ultimately improve patient outcomes.
Susan holds a bachelor’s degree in nursing from West Chester University in Pennsylvania and a Master of Science in nursing from Wayne State University.